Charles River Laboratories raises annual profit forecast on stabilizing biotech demand
(Reuters) – Charles River Laboratories raised its full-year profit forecast after beating analysts’ estimates for quarterly results as the contract research firm expects demand to stabilize from biotech clients for its drug discovery and development …